Page last updated: 2024-09-03

imatinib mesylate and Cancer of Jejunum

imatinib mesylate has been researched along with Cancer of Jejunum in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (41.67)29.6817
2010's12 (50.00)24.3611
2020's2 (8.33)2.80

Authors

AuthorsStudies
Akita, H; Amagasa, H; Ami, K; Ando, M; Chong, JM; Fukuda, A; Ganno, H; Iida, S; Imai, K; Kajiyama, D; Kawaguchi, M; Maeda, F; Motoyama, K; Tokito, F; Yamada, A1
Fernández, JA; Ferreras, D; Ferri, B; Frutos, MD; Martínez, J; Olivares, V; Ruiz-Manzanera, JJ1
Agud Fernández, M; Díaz Pedroche, C; Gómez-Martín, C; López López, F1
Ananiadis, A; Atmatzidis, K; Atmatzidis, S; Chatzimavroudis, G; Kapoulas, S1
He, D; Hou, Y; Hu, Q; Jiang, D; Liu, J; Liu, Y; Lu, S; Lu, W; Shi, Y; Tan, Y; Xu, C; Zhu, X1
Kimura, H; Mizuuchi, Y; Oda, Y; Ohtsuka, T; Takahata, S; Tanaka, M; Toma, H; Ueda, J; Ueki, T; Yamamoto, H1
Altinay, S; Kusaslan, R1
Kirii, Y; Misawa, S; Ota, H; Sakamoto, H; Takagi, H; Takeda, M1
Chang, YR; Han, IW; Jang, JY; Kang, MJ; Kim, SW; Kwon, W; Lee, HJ; Lee, KB; Park, JW; Park, KJ1
Funahashi, W; Harada, A; Hasegawa, H; Ikeda, Y; Kabashima, A; Kitagawa, D; Kondo, N; Nakamura, T; Shoji, F; Teramoto, S1
Lanzon-Miller, S; Sadeghi, P1
Kanazawa, Y; Nemoto, T; Ohira, H; Ozaki, A; Sawano, T; Tsukada, M1
Guo, RP; Guo, ZX; Lao, XM; Li, JQ; Wang, GH; Ye, ZY; Zhang, YQ1
Ben Slama, S; Bouraoui, S; Gharbi, L; Gharbi, W; Goutallier, C; Lahmar-Boufaroua, A; Manai, S; Mzabi-Regaya, S1
Akasaka, H; Hakamada, K; Koyama, M; Morohashi, H; Murata, A; Sakamoto, Y; Yokoyama, H1
Funaki, H; Kaida, D; Kinami, S; Kosaka, T; Minato, H; Morioka, E; Nakano, Y; Nakata, S; Noguchi, M; Ohnishi, T; Ohno, Y; Omote, K; Takamura, H; Tomita, Y; Ueda, N1
Chander, S; Lay Ergun, E; Shields, AF1
Godény, M; Hitre, E; Horváth, Z; Láng, I1
Ishikawa, N; Kyouno, S; Ohaki, Y; Seya, T; Shirakawa, T; Tajiri, T; Takahashi, Y; Tanaka, N; Yamashita, K; Yokoi, K1
Aoki, R; Imoto, Y; Ito, S; Muguruma, N; Nakamoto, J; Okamoto, K; Okamura, S; Okitsu, H; Sano, T; Sato, Y1
Goto, T; Igaki, N; Kanda, S; Matsuda, T; Ohyama, M; Takashima, M; Tamada, F1
Aschoff, AJ; Henne-Bruns, D; Kramer, K; Siech, M; Sträter, J1
Ide, H; Ito, T; Iwase, K; Kainuma, S; Michiura, T; Mikata, S; Mizushima, T; Nonaka, K; Yamanaka, H1
Chang, HM; Kang, HJ; Kang, YK; Kim, HC; Kim, JS; Kim, JY; Kim, TW; Lee, H; Lee, JL; Park, JH; Ryu, MH1

Reviews

2 review(s) available for imatinib mesylate and Cancer of Jejunum

ArticleYear
Spontaneous rupture of a giant gastrointestinal stromal tumor of the jejunum: a case report and literature review.
    World journal of surgical oncology, 2014, May-21, Volume: 12

    Topics: Aged; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Male; Peritoneal Neoplasms; Piperazines; Prognosis; Pyrimidines; Rupture, Spontaneous; Tomography, X-Ray Computed

2014
[Umbilical Hernia Complicated by Gastrointestinal Stromal Tumor of the Small Intestine - A Case Report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12

    Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Hernia, Umbilical; Humans; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed

2016

Other Studies

22 other study(ies) available for imatinib mesylate and Cancer of Jejunum

ArticleYear
[Case of Peritoneal Dissemination from Gastrointestinal Stromal Tumor of Jejunum Treated with Repeated Non-Curative Surgery].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:1

    Topics: Aged; Antineoplastic Agents; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Jejunum; Liver Neoplasms; Male

2020
Characteristics and prognosis of jejunoileal gastrointestinal stromal tumours (GISTs) in the era of imatinib: a comparative study with gastric GISTs.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:7

    Topics: Aged; Antineoplastic Agents; Disease-Free Survival; Female; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate

2021
Concurrent inflammatory bowel disease and gastrointestinal stromal tumor.
    Gastroenterologia y hepatologia, 2018, Volume: 41, Issue:5

    Topics: Aged, 80 and over; Combined Modality Therapy; Crohn Disease; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Immunosuppressive Agents; Intestinal Obstruction; Intestinal Pseudo-Obstruction; Jejunal Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Sunitinib

2018
Giant GIST of the small intestine in a young man.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2013, Volume: 17, Issue:8

    Topics: Adult; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Male; Piperazines; Pyrimidines; Radiography

2013
Subsequent intra-abdominal fibromatosis mimicking recurrent gastrointestinal stromal tumor.
    Diagnostic pathology, 2013, Jul-31, Volume: 8

    Topics: Antineoplastic Agents; Benzamides; Diagnostic Errors; Digestive System Surgical Procedures; Duodenal Neoplasms; Fibromatosis, Abdominal; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Predictive Value of Tests; Pyrimidines; Reoperation; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Unnecessary Procedures

2013
[A case of gastrointestinal stromal tumor of the jejunum successfully treated by preoperative induction chemotherapy with imatinib mesylate administered through jejunostomy and subsequent surgical resection].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:3

    Topics: Aged; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Jejunostomy; Piperazines; Pyrimidines

2014
Gastrointestinal autonomic nerve tumour of jejunum presenting as a perforated mass.
    JPMA. The Journal of the Pakistan Medical Association, 2014, Volume: 64, Issue:4

    Topics: Abdomen, Acute; Aged; Antineoplastic Agents; Autonomic Nervous System Diseases; Benzamides; Combined Modality Therapy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Jejunal Neoplasms; Male; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Sarcoma

2014
Clinicopathologic analysis of gastrointestinal stromal tumors in duodenum and small intestine.
    World journal of surgery, 2015, Volume: 39, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Mitotic Index; Neoplasm Staging; Piperazines; Pyrimidines; Retrospective Studies; Rupture, Spontaneous; Survival Analysis; Survival Rate; Young Adult

2015
[No recurrent case of the combination of surgical management with chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12

    Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Piperazines; Pyrimidines; Sigmoid Neoplasms; Tomography, X-Ray Computed

2014
A jejunal GIST presenting with obscure gastrointestinal bleeding and small bowel obstruction secondary to intussusception.
    BMJ case reports, 2015, Nov-02, Volume: 2015

    Topics: Aged; Antineoplastic Agents; Capsule Endoscopy; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Intussusception; Jejunal Neoplasms; Male; Treatment Outcome

2015
A gastrointestinal stromal tumor of the jejunum associated with intrahepatic cholangiocarcinoma and pulmonary hamartoma: a case report.
    Acta oncologica (Stockholm, Sweden), 2009, Volume: 48, Issue:6

    Topics: Antineoplastic Agents; Benzamides; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Gastrointestinal Stromal Tumors; Hamartoma; Humans; Imatinib Mesylate; Jejunal Neoplasms; Lung Diseases; Male; Middle Aged; Piperazines; Protein-Tyrosine Kinases; Pyrimidines

2009
[Review of 32 gastro-intestinal stromal tumours with CD117 antigen].
    La Tunisie medicale, 2009, Volume: 87, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Duodenal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Retrospective Studies; Stomach Neoplasms; Treatment Outcome

2009
[A case of recurrent intestinal GIST with long-term survival-beneficial effect of multimodality therapy using high-dose imatinib and surgery].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:12

    Topics: Aged; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Piperazines; Pyrimidines; Recurrence; Time Factors

2012
[A case of drug resistant recurrent gastrointestinal stromal tumor treated surgically by resection, partial hepatectomy and diaphragmectomy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:12

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Diaphragm; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Hepatectomy; Humans; Imatinib Mesylate; Indoles; Jejunal Neoplasms; Liver Neoplasms; Male; Peritoneal Neoplasms; Piperazines; Pyrimidines; Pyrroles; Recurrence; Sunitinib

2012
An FDG positron emission tomographic study in a case of gastrointestinal stromal tumor.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:4

    Topics: Appendiceal Neoplasms; Benzamides; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Jejunal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome

2003
Case 3. Resection of originally inoperable liver metastases of gastrointestinal stromal tumor after imatinib mesylate therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-15, Volume: 21, Issue:18

    Topics: Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Jejunal Neoplasms; Liver Neoplasms; Piperazines; Pyrimidines

2003
High efficacy of imatinib for recurrent gastrointestinal stromal tumor in the jejunum: a case report.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2004, Volume: 71, Issue:2

    Topics: Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Jejunal Neoplasms; Mesenchymoma; Middle Aged; Piperazines; Pyrimidines; Treatment Outcome

2004
A treatment using STI571 for jejunal gastrointestinal stromal tumor (GIST) accompanied with liver metastasis and peritoneal dissemination.
    Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:12

    Topics: Antineoplastic Agents; Benzamides; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines; Tomography, X-Ray Computed

2004
Malignant gastrointestinal stromal tumor of the small intestine complicated with pulmonary tuberculosis during treatment with imatinib mesylate.
    Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:2

    Topics: Administration, Oral; Antineoplastic Agents; Antitubercular Agents; Benzamides; Combined Modality Therapy; Digestive System Surgical Procedures; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Laparotomy; Leiomyosarcoma; Liver Neoplasms; Male; Middle Aged; Neutropenia; Piperazines; Pyrimidines; Tomography, X-Ray Computed; Tuberculosis, Pulmonary

2005
[GI hemorrhage with fulminant shock induced by jejunal gastrointestinal stromal tumor (GIST) coincident with duodenal neuroendocrine carcinoma (NET) + neurofibromatosis (NF) -- case report and review of the literature].
    Zeitschrift fur Gastroenterologie, 2005, Volume: 43, Issue:3

    Topics: Adult; Antineoplastic Agents; Benzamides; Carcinoma, Neuroendocrine; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Duodenal Neoplasms; Duodenum; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Jejunal Neoplasms; Neurofibromatosis 1; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Shock, Hemorrhagic; Time Factors; Tomography, Spiral Computed; Treatment Outcome

2005
[Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:13

    Topics: Antineoplastic Agents; Benzamides; Drug Administration Schedule; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Piperazines; Pyrimidines; Remission Induction

2005
Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.
    Digestive diseases and sciences, 2006, Volume: 51, Issue:6

    Topics: Abdominal Pain; Aged; Antineoplastic Agents; Benzamides; Diagnosis, Differential; DNA; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jejunal Neoplasms; Mutation; Neurofibromatosis 1; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Tomography, X-Ray Computed

2006